GVR Report cover Post-marketing Pharmacovigilance and Medical Information Market Size & Forecast By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Product (Books, Online Media, Journals), By End-use (Hospitals, Research organization) And Trend Report

Post-marketing Pharmacovigilance and Medical Information Market Size & Forecast By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Product (Books, Online Media, Journals), By End-use (Hospitals, Research organization) And Trend Analysis From 2012 - 2022

  • Report ID: 978-1-68038-758-2
  • Number of Report Pages: 115
  • Format: PDF, Horizon Databook
  • Historical Data: 2013-2015
  • Forecast Period: 2016 - 2022 
  • Industry: Healthcare

Report Overview

The global post-marketing pharmacovigilance and medical information market size was valued at USD 2.02 billion in 2014. Rising demand for new drug development coupled with presence of technologically advanced, easily accessible medical information system is expected to boost the market growth over the forecast period.

Post-marketing pharmacovigilance penetration and future growth opportunities, bytype of reporting

Post-marketing pharmacovigilance penetration and future growth opportunities

As per the ISMP (Institute for Safe Medication Practices), approximately two of every three patients who visit a doctor leave with at least one prescription drug. Drug consumption has increased substantially owing to rapidly growing disease prevalence rates. Approximately 6.4 billion drugs were dispensed in the U.S. alone in 2014. Rise in the prevalence of chronic diseases such as cardiovascular & respiratory disorders, oncology, and diabetes have increased the consumption of drugs worldwide.All the aforementioned factors are attributing to the post-marketing pharmacovigilance and medical information market growth in near foreseeable future.

Furthermore, increasing incidences of adverse drug reactions impose a substantial burden on healthcare systems and is one of the prominent reasons of morbidity in developed countries. According to the ISMP, currently, more than 10,000 prescription drugs and 300,000 over-the-counter (OTC) medications are available in the U.S. It has also been stated that nearly 1.5 million preventable ADRs (Adverse Drug Reactions) occur in the U.S. each year. Growing instances of ADRs resulting in drug withdrawals is expected to drive market growth during the forecast period.

Type Insights

Post marketing surveillance (PMS) information is collected via methods such as spontaneous reporting, cohort event reporting, targeted spontaneous reporting, intensified ADR reporting, and EHR Mining. Spontaneous reporting dominated the product segment as of 2014, owing to wide application in post market surveillance activities. Cohort event monitoring is expected to grow with lucrative CAGR of 13.5% during the forecast period due to introduction of technologically advanced cloud-based platforms and reliability on information obtained by this system.

Products Insights

The product segment constitutes books, online media, and journals. Books on pharmacovigilance held the largest share of over 39.0% in 2014. Increasing usage of printed books in academics and research institutes is attributing to its higher penetration. Technological advancements such as digitalization of medical information, for easy access are responsible for the growth of the online media segment. It is expected to grow at a CAGR of over 13.0% over the forecast period.

End-use Insights

Post-marketing pharmacovigilance and medical information services are used in research organizations for monitoring & regulating drug safety guidelines, hospitals for adverse drug effects reporting. The research organization segment is expected to show a lucrative growth rate of over 13.0% in the coming years due to increasing R&D for the development of novel drugs and medical devices. Advancements in cloud-based medical information system such as Argus safety by Oracle and ARIS safety suite by ArisGlobal, are further growth propellers for this market.

Regional Insights

North America held the largest revenue share of the overall industry in 2014 at over 38.0%. Increasing demand for new drug development coupled with incidences of adverse drug reporting are key drivers for this regional market. Rising adoption of Electronic Health Records (EHR), supportive infrastructure and healthcare expenditure is further expected to fuel the growth of this regional industry. Asia Pacific region is expected to show lucrative growth in future due to increasing outsourcing activities, improving healthcare infrastructure, and rising demand for pharmacovigilance activities.

Key Companies & Market Share Insights

Post-marketing pharmacovigilance and medical information market is catered by players such Accenture Plc, Clinquest Group, B.V., Cognizant Technology Solutions Corp., Covance Inc., iMEDGlobal Corp., inVentiv Health Clinical, Parexel International Corporation, Pharmaceutical Product Development Inc, PRA Health Sciences, Quintiles Transnational Corporation, F. Hoffmann-La Roche Ltd. Sanofi, Synowledge, Wipro Ltd., ArisGlobal, and Ergomed.

The market is highly competitive in nature and manufacturers are focusing on strategies such as merger & acquisition, collaborative agreements, and new product development for sustaining the competition and gain more industry share. Presence of a competitive environment has led to the streamlining of R&D, manufacturing operations, medical writing, pharmacovigilance, and clinical data management. Manufacturers are rapidly adhering to outsourcing as a viable cost curbing tool.

Post-marketing Pharmacovigilance And Medical Information Market Report Scope

Report Attribute


Market size value in 2020

USD 44.3 billion

Revenue forecast in 2022

USD 5.3 billion

Growth Rate

CAGR of 15.1% from 2019 to 2027

Base year for estimation


Historical data

2013 - 2015

Forecast period

2016 - 2022

Quantitative units

Revenue in USD million and CAGR from 2016 to 2022

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, product, end-use, region

Regional scope

North America; Europe; APAC; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Japan; China; India; Brazil; Mexico; South Africa

Key companies profiled

Accenture Plc; Clinquest Group, B.V.; Cognizant Technology Solutions Corp.; Covance Inc.; iMEDGlobal Corp.; inVentiv Health Clinical; Parexel International Corporation; Pharmaceutical Product Development Inc; PRA Health Sciences; Quintiles Transnational Corporation; F. Hoffmann-La Roche Ltd. Sanofi; Synowledge; Wipro Ltd.; ArisGlobal; Ergomed

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.